Clinical Trials

Nasopharyngeal Carcinoma, Recurrence

NCT06976190 2026-01-20

Magic-C002

Phase 3 Recruiting

446 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma, Recurrence

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

150 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Neoplasms, Recurrence

NCT06525350 2024-07-29

A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer

256 enrolled

Recurrence

NCT02889666 2024-04-17

CCODG-NSCLC

Phase 1 Recruiting

500 enrolled

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT03620123 2022-11-18

OPTIM

54 enrolled

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT02460367 2022-04-06

Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer

Phase 1 Terminated

16 enrolled

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Phase 2/3 Terminated

135 enrolled

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02322281 2019-08-14

TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy

Phase 3 Terminated

149 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT02007148 2019-02-27

MICADO

Phase 2 Unknown

51 enrolled

Neoplasm Metastasis, Recurrence

NCT02346370 2019-02-08

PRIMAL

Phase 1 Terminated

16 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

180 enrolled

Gastrointestinal

Recurrence, Stomach Neoplasms

NCT00454779 2018-10-17

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

113 enrolled 18 charts

Neoplasm Metastasis, Recurrence

NCT01794845 2017-05-11

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Phase 2 Terminated

5 enrolled 9 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Recurrence

NCT00378404 2015-06-08

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

Phase 1 Terminated

10 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

35 enrolled

Sarcoma

Recurrence, Sarcoma

NCT00095199 2012-10-15

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

Phase 3 Completed

939 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT00231855 2012-04-24

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

31 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts